Aelis Farma (EURONEXT: AELIS) announced recruitment has begun for its phase 2B clinical trial testing AEF0217 for behavioral and cognitive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE